Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Korc

Showing results (101-110 of 203) with videos related to

Pageof 21
Sort By:
American Journal of Surgery|October 27, 1997
Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitisD Hsiang, H Friess, M W Büchler, et al.
The Journal of Clinical Investigation|October 1, 1992
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alphaM Korc, B Chandrasekar, Y Yamanaka, et al.
International Journal of Cancer|October 1, 1998
Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancerM Wagner, J Kleeff, M E Lopez, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 1, 1996
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptorsH Friess, P Berberat, M Schilling, et al.
International Journal of Cancer|March 1, 1994
Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitisH Friess, Y Yamanaka, M Büchler, et al.
Pancreas|November 15, 1997
Altered expression of insulin-like growth factor II receptor in human pancreatic cancerT Ishiwata, U Bergmann, M Kornmann, et al.
Cancer Communications|May 1, 1991
Effects of epidermal growth factor on growth response, morphology, and invasive potential of human endometrial carcinoma cell line RL95-2P Sundareshan, R L Misiorowski, J R Davis, et al.
Cell Death & Disease|October 16, 2015
Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinomaL R Palam, J Gore, K E Craven, et al.
Anticancer Research|May 1, 1993
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressivenessY Yamanaka, H Friess, M S Kobrin, et al.
Oncogene|September 5, 2012
AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasiaA M Norris, A Gore, A Balboni, et al.
Pageof 21

Showing results (101-110 of 203) with videos related to

Sort By:
Pageof 21
American Journal of Surgery|October 27, 1997
Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitisD Hsiang, H Friess, M W Büchler, et al.
The Journal of Clinical Investigation|October 1, 1992
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alphaM Korc, B Chandrasekar, Y Yamanaka, et al.
International Journal of Cancer|October 1, 1998
Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancerM Wagner, J Kleeff, M E Lopez, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 1, 1996
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptorsH Friess, P Berberat, M Schilling, et al.
International Journal of Cancer|March 1, 1994
Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitisH Friess, Y Yamanaka, M Büchler, et al.
Pancreas|November 15, 1997
Altered expression of insulin-like growth factor II receptor in human pancreatic cancerT Ishiwata, U Bergmann, M Kornmann, et al.
Cancer Communications|May 1, 1991
Effects of epidermal growth factor on growth response, morphology, and invasive potential of human endometrial carcinoma cell line RL95-2P Sundareshan, R L Misiorowski, J R Davis, et al.
Cell Death & Disease|October 16, 2015
Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinomaL R Palam, J Gore, K E Craven, et al.
Anticancer Research|May 1, 1993
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressivenessY Yamanaka, H Friess, M S Kobrin, et al.
Oncogene|September 5, 2012
AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasiaA M Norris, A Gore, A Balboni, et al.
Pageof 21